Ayaka Isogai, Mitsuo Terada, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Makiko Mori, Kazuki Nozawa, Nana Matsumoto, Yuka Niwa, Yuya Tanaka, et al. Optimal patient population for adjuvant S-1 therapy in hormone receptor-positive, HER2-negative early breast cancer. Breast cancer (Tokyo, Japan). 2025
N Matsumoto, Y Wanifuchi-Endo, T Fujita, T Asano, M Terada, K Nozawa, M Mori, A Isogai, Y Niwa, H Kato, et al. Prognosis, clinicopathological characteristics, and treatment patterns of patients with ER-intermediate-positive breast cancer undergoing long-term follow-up. ESMO open. 2025. 10. 4. 104508-104508
Yuka Endo, Haruru Kotani, Nobuko Tamura, Kiyo Tanaka, Chiho Kudo, Masataka Sawaki, Masaya Hattori, Akiyo Yoshimura, Ayumi Kataoka, Kazuki Nozawa, et al. Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy. Breast cancer (Tokyo, Japan). 2024
Ayaka Isogai, Kazuki Nozawa, Akira Nakakami, Rie Komaki, Yuri Ozaki, Yuka Endo, Ayumi Kataoka, Haruru Kotani, Akiyo Yoshimura, Masaya Hattori, et al. Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study. Breast cancer research and treatment. 2024. 207. 2. 253-261
Nanae Horisawa, Akiyo Yoshimura, Isao Oze, Masataka Sawaki, Masaya Hattori, Haruru Kotani, Ayumi Kataoka, Yuri Ozaki, Kazuki Nozawa, Yuka Endo, et al. Supraclavicular Irradiation Induces Lymphedema in Breast Cancer Patients Treated with Axillary Lymph Node Dissection and Taxane-Containing Chemotherapy. The breast journal. 2024. 2024. 3250143-3250143